| 000 | 01336 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513110145.0 | ||
| 264 | 0 | _c19970311 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0936-6555 | ||
| 024 | 7 |
_a10.1016/s0936-6555(96)80079-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCook, A M | |
| 245 | 0 | 0 |
_aComparison of mitozantrone and epirubicin in advanced breast cancer. _h[electronic resource] |
| 260 |
_bClinical oncology (Royal College of Radiologists (Great Britain)) _c1996 |
||
| 300 |
_a363-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEpirubicin _xadverse effects |
| 650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadverse effects |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChambers, E J | |
| 700 | 1 | _aRees, G J | |
| 773 | 0 |
_tClinical oncology (Royal College of Radiologists (Great Britain)) _gvol. 8 _gno. 6 _gp. 363-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0936-6555(96)80079-3 _zAvailable from publisher's website |
| 999 |
_c8965561 _d8965561 |
||